Moderna raises 2026 outlook as CEO says newer vaccines are gaining traction

by admin 0 Comments

Earnings
Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

The biotech company now expects 2026 revenue growth of 15% to 25%, up from its previous guidance of up to 10%. 

Read the original report.

Share on Facebook
Share on Twitter
Share on Pinterest
Share on LinkedIn

Articles You May Like

California’s billionaire tax faces defeat, but Democrats plan higher taxes on the wealthy
Two years after the floods, Ingham homeowners say insurance is out of reach
Barkin sees interest rate hikes ahead, but at a gradual pace
Panda Mart told to shut two Melbourne stores again over unsafe goods
CNBC’s experts on whether the AI trade is ending and what investors should do next

Leave a Reply

Your email address will not be published. Required fields are marked *